TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kintor Pharmaceutical Ltd ( (HK:9939) ) has issued an announcement.
Kintor Pharmaceutical Limited announced an increase in shareholding by its Chairman, Dr. Youzhi Tong, who purchased 200,000 shares and exercised rights under 1,250,000 restricted share units, bringing his total interest to approximately 10.99% of the company’s issued share capital. This move reflects Dr. Tong’s confidence in the company’s growth potential and long-term investment value, as Kintor continues to focus on expanding its dermatology product line and exploring new markets for its cosmetic ingredients.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company focused on the dermatology industry, primarily involved in the development and commercialization of cosmetics products. The company is actively expanding its product offerings and exploring new market opportunities, particularly in the area of functional cosmetic ingredients.
YTD Price Performance: 14.43%
Average Trading Volume: 3,698,500
Technical Sentiment Signal: Buy
Current Market Cap: HK$510.7M
Learn more about 9939 stock on TipRanks’ Stock Analysis page.